Status:
COMPLETED
MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial
Lead Sponsor:
MicroPhage, Inc.
Conditions:
Bacteremia
Staphylococcal Infection
Eligibility:
All Genders
18+ years
Brief Summary
In-vitro identification of S. aureus, methicillin-sensitive S. aureus (MSSA), and methicillin-resistant S. aureus (MRSA) from positive blood cultures by MicroPhage's bacteriophage-based diagnostic pla...
Detailed Description
This is a multi-center, preclinical study to investigate the effectiveness of the performance of MicroPhage S. aureus / MSSA/MRSA test direct for blood culture. There will be no patient consent, as th...
Eligibility Criteria
Inclusion
- Over 18 years of age.
- Blood culture positive, of ANY of the following bottle types:
- BD Bactec Standard Aerobic and Anaerobic,
- BD Bactec Plus Aerobic and Anaerobic,
- bioMerieux BacT/Alert Standard Aerobic and Anaerobic,
- bioMerieux BacT/Alert FAN Aerobic and Anaerobic.
Exclusion
- BD Bactec Lytic, Pediatric, or other bottle types not listed above.
- bioMerieux Pediatric FAN or other bottle types listed above.
- Trek bottles.
- Specimens from patients under 18 years of age.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
712 Patients enrolled
Trial Details
Trial ID
NCT00814151
Start Date
July 1 2008
End Date
December 1 2008
Last Update
December 24 2008
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Evanston Northwestern Healthcare Research Institute
Evanston, Illinois, United States, 60201
2
University of Maryland Baltimore
Baltimore, Maryland, United States, 21201
3
Johns Hopkins Medical Institute
Baltimore, Maryland, United States, 21287